Lunit

328130.KQ

32.10 USD

-0.97

-2.93%

Overview

Last close

32.10 usd

Market cap

925.33M usd

52 week high

90.42 usd

52 week low

17.59 usd

Target price

74.64 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

47.6191

Price/Book Value

5.1861

Enterprise Value

908.71M usd

EV/Revenue

46.7639

EV/EBITDA

-45.3273

Key financials

Revenue TTM

19.43M usd

Gross Profit TTM

4.96M usd

EBITDA TTM

-43.02M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

453.95B usd

Net debt

N/A usd

About

Lunit Inc. develops and provides AI based software solutions for cancer screening/diagnosis and treatment. It offers AI solution for chest X-ray and mammography, as well as AI-powered biomarker for immune phenotyping and PD-L1 quantification for immunotherapy. The company was incorporated in 2013 and is based in Seoul, South Korea.